title: Effect of Shifting from Combination Therapy to Monotherapy of α-Blockers or 5α-Reductase Inhibitors on Prostate Volume and Symptoms in Patients with Benign Prostatic Hyperplasia.
abstract: OBJECTIVE
  Combination therapy of α-blockers and 5α-reductase inhibitors (5-ARIs) is widely used for the treatment of benign prostatic hyperplasia (BPH). We aimed to study the effect on prostate volume and symptoms of shifting to monotherapy in patients who previously received a combination therapy.
  
  
  METHODS
  A prospective study was conducted of 60 patients who were diagnosed with BPH. Patients were aged 45 years or older and had a prostate volume of 30 cc or more, International Prostate Symptom Score (IPSS) of 12 or above, maximal flow rate (Qmax) of 15 ml/s or less, and prostate-specific antigen (PSA) level of less than 10 ng/ml. The patients initially received a combination therapy of doxazosin 4 mg/day and finasteride 5 mg/day for 3 months and were then randomly assigned to receive monotherapy for 3 months. The factors were then compared.
  
  
  RESULTS
  A total of 30 patients were assigned to doxazosin (group 1) and 30 to finasteride (group 2) after the combination therapy. The percentage changes in prostate volume, IPSS, and Qmax during the period from post-combination therapy to post-monotherapy were not significantly different between the two groups (p=0.052, 0.908, 0.081), whereas PSA significantly decreased in group 2 (p<0.001). IPSS was not significantly different at post-combination therapy and at post-monotherapy in both groups (p=0.858, 0.071). The prostate volume significantly increased from 40.97 cc at post-combination therapy to 44.29 cc at post-monotherapy in group 1 (p=0.001) and insignificantly increased from 38.32 cc to 38.61 cc in group 2 (p=0.696).
  
  
  CONCLUSIONS
  Although the duration of drug administration was short in this study, 5-ARI monotherapy could maintain the alleviated symptoms and reduce the risk of acute urinary retention and surgery due to prostate regrowth in BPH patients whose symptoms improved with combination therapy.
authors.affiliation: Department of Urology, Sahmyook Medical Center, Seoul, Korea.
authors.forename: Hyoung Woo
authors.initials: HW
authors.lastname: Kim
authors.forename: Dae Geun
authors.initials: DG
authors.lastname: Moon
authors.forename: Hyun Min
authors.initials: HM
authors.lastname: Kim
authors.forename: Jong Ho
authors.initials: JH
authors.lastname: Hwang
authors.forename: Soon Chan
authors.initials: SC
authors.lastname: Kim
authors.forename: Sam Geuk
authors.initials: SG
authors.lastname: Nam
authors.forename: Jun Tag
authors.initials: JT
authors.lastname: Park
references.citation: Urology. 2003 Jan;61(1):119-26
references.pmid: 12559281
references.citation: Urology. 2006 Nov;68(5):1015-9
references.pmid: 17095071
references.citation: J Urol. 2003 Aug;170(2 Pt 1):530-47
references.pmid: 12853821
references.citation: Urology. 2001 Aug;58(2):203-9
references.pmid: 11489700
references.citation: Urology. 1988 Dec;32(6 Suppl):16-20
references.pmid: 2462300
references.citation: Urol Clin North Am. 1993 Nov;20(4):627-36
references.pmid: 7505970
references.citation: Urology. 2003 Feb;61(2):267-73
references.pmid: 12597928
references.citation: Urology. 1997 Oct;50(4):556-61
references.pmid: 9338731
references.citation: Urology. 2004 Dec;64(6):1144-8
references.pmid: 15596187
references.citation: N Engl J Med. 1992 Oct 22;327(17):1185-91
references.pmid: 1383816
references.citation: N Engl J Med. 1998 Feb 26;338(9):557-63
references.pmid: 9475762
references.citation: Can Urol Assoc J. 2008 Feb;2(1):16-21
references.pmid: 18542722
references.citation: Urology. 2009 Apr;73(4):802-6
references.pmid: 19193422
references.citation: Prostate. 2001 Jan 1;46(1):45-51
references.pmid: 11170131
references.citation: Korean J Urol. 2010 Jul;51(7):488-91
references.pmid: 20664783
references.citation: Br J Urol. 1978 Dec;50(7):551-4
references.pmid: 88984
references.citation: Urol Int. 2001;66(2):84-8
references.pmid: 11223749
references.citation: J Urol. 1992 May;147(5):1298-302
references.pmid: 1373779
references.citation: Am J Geriatr Pharmacother. 2005 Jun;3(2):103-14
references.pmid: 16129387
references.citation: J Urol. 2002 Apr;167(4):1734-9
references.pmid: 11912399
references.citation: N Engl J Med. 2003 Dec 18;349(25):2387-98
references.pmid: 14681504
references.citation: Urology. 2002 Feb;59(2 Suppl 1):1-2
references.pmid: 11832306
references.citation: N Engl J Med. 1996 Aug 22;335(8):533-9
references.pmid: 8684407
references.citation: J Urol. 1989 Feb;141(2):248-53
references.pmid: 2643720
references.citation: Eur Urol. 2003 Oct;44(4):461-6
references.pmid: 14499682
references.citation: Prostate. 1999 Jun 1;39(4):234-9
references.pmid: 10344212